ARTICLE | Clinical News
Joicela lumiracoxib regulatory update
April 25, 2011 7:00 AM UTC
Novartis withdrew an MAA in Europe for Joicela lumiracoxib in combination with a companion diagnostic to treat osteoarthritis (OA) of the knee and hip in patients who do not carry the 0102 allele of ...